"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Agitation is a neuropsychiatric symptom in patients with Alzheimer's disease (AD), the most common form of dementia. The prevalence of this symptom is about 40%-65% ...

When agitated dementia patients wander or shout through the night, families and caregivers understandably feel the need to ...

The next meeting of the monthly dementia education and support group at Senior Commons at Powder Mill will explore ...

Please provide your email address to receive an email when new articles are posted on . The model, along with a traffic-light system, boosted sensitivity and specificity of agitation recognition.

"We need to find ways to engage frontline staff in the delivery of nonpharmaceutical interventions, including early preferred music, to achieve the goal of safe and effective management of ...

Alzheimer’s disease often presents a range of challenging symptoms, and agitation stands out as one of the most complex for caregivers and healthcare providers to manage. This is especially true for ...

This is a prescription for disaster. While all medications carry potential side effects, certain types have been shown to ...

Contrary to what many people believe, dementia is not a normal part of aging. Dementia is also not a specific disease, but rather a term that describes the cognitive changes that negatively affect ...